When did iRadimed report Q1 2025 earnings?

iRadimed (IRMD) reported Q1 2025 earnings on May 5, 2025 before market open.

What were iRadimed's Q1 2025 revenue and EPS?

iRadimed reported revenue of $19.5M and eps of $0.42 for Q1 2025.

Did iRadimed beat estimates in Q1 2025?

Revenue beat the consensus estimate of $19.3M by $178.6K. EPS missed the consensus estimate of $0.43 by $0.01.

How did iRadimed's Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 10.9% from $17.6M a year earlier and eps grew 16.7% from $0.36.

Where can I find iRadimed's Q1 2025 SEC filings?

You can read the 10-Q periodic report (0001558370-25-006308) directly on SEC EDGAR. The filing index links above go to sec.gov.

iRadimed IRMD Q1 2025 earnings

Reported May 5, 2025 · Before market open

Revenue$19.5MBeat by $178.6K

EPS$0.42Miss by $0.01

Revenue estimate$19.3M

EPS estimate$0.43

Next report

Jul 31, 2026 (In 2 days)

Revenue estimate$20.4M

EPS estimate$0.42

Financials

Q1 2025

Income statement

See full

Revenue$19.5M+10.9%

Gross profit$14.8M+10.9%

Operating income$5.4M+14.4%

Net income$4.7M+13.3%

EPS (diluted)$0.37+15.6%

Balance sheet

See full

Cash & equivalents$50.3M+11.5%

Total debt$59.2K-96.9%

Total equity$90.1M+18.3%

Total assets$101.7M+15.6%

Cash flow

See full

Operating cash flow$4.3M+10.5%

CapEx$3.7M+1,266%

Free cash flow$595.0K-83.5%

Valuation & ratios

Valuation

as of 03/31/25

See full

Market cap$667.29M+19.8%

Enterprise value$617.02M+20.1%

P/E33.7×+2.6×

P/S8.9×+0.6×

Profitability

See full

Gross margin76.9%+0.3pp

Operating margin30.1%-0.6pp

Net margin26.3%-0.2pp

FCF margin19.4%+2.6pp

Returns & leverage

See full

Return on equity23.8%-1.7pp

Debt / equity0×0.0×

Current ratio8.9×-0.6×

Segments

By product

See full

MRI Compatible Patient Vital Signs Monitoring Systems$6.5M—

MRI Compatible IV Infusion Pumps$6.0M—

Ferro Magnetic Detection Systems$418.0K—

Versus estimates

Revenue

Q1 2026$22.0MBeat by $664.0K Q4 2025$22.7MBeat by $1.1M Q3 2025$21.2MMiss by $394.9K Q2 2025$20.4MMiss by $89.1K

Q1 2025$19.5MBeat by $178.6K

Q4 2024$19.4MBeat by $189.2K

Diluted EPS

Q1 2026$0.49Beat by $0.03 Q4 2025$0.54Beat by $0.05 Q3 2025$0.47Miss by $0.01 Q2 2025$0.49Beat by $0.04

Q1 2025$0.42Miss by $0.01

Q4 2024$0.44Miss by $0.01

Ask the moment iRadimed reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did iRadimed report Q1 2025 earnings?: iRadimed (IRMD) reported Q1 2025 earnings on May 5, 2025 before market open.
What were iRadimed's Q1 2025 revenue and EPS?: iRadimed reported revenue of $19.5M and eps of $0.42 for Q1 2025.
Did iRadimed beat estimates in Q1 2025?: Revenue beat the consensus estimate of $19.3M by $178.6K. EPS missed the consensus estimate of $0.43 by $0.01.
How did iRadimed's Q1 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 10.9% from $17.6M a year earlier and eps grew 16.7% from $0.36.
Where can I find iRadimed's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001558370-25-006308) directly on SEC EDGAR. The filing index links above go to sec.gov.